Visura develops visualization solutions for transesophageal echocardiogram (TEE) probe intubations, centered on its TEECAD System. The TEECAD System is an FDA-cleared, disposable camera that connects to a TEE probe to provide physicians real-time visualization for more efficient and effective probe placement. The company was founded in 2015 by David Marmor, MD, and is led by president and CEO Christine Horton. Visura is based in Minneapolis, MN. The company plans to use recent funding to support commercialization of the TEECAD System and to bring the technology to heart centers across the U.S. In 2022 Visura released a product update expanding TEECAD compatibility to include the Philips X8-2t transducer, and it also recently received a Launch Minnesota Innovation Grant.

Total raised

$4M

Funding rounds

1

Latest round

Series B

Latest activity

Jan 2023